Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Boeve

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Neurology|January 28, 2012
The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of AgingR O Roberts, Y E Geda, D S Knopman, et al.
Neurology|September 30, 2009
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutationsJ L Whitwell, C R Jack, B F Boeve, et al.
Neurology|March 4, 2009
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRNJ L Whitwell, C R Jack, B F Boeve, et al.
Neurology|December 22, 2010
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?J L Whitwell, C R Jack, J E Parisi, et al.
Radiology|March 29, 2001
Mild cognitive impairment and Alzheimer disease: regional diffusivity of waterK Kantarci, C R Jack, Y C Xu, et al.
Neurology|July 26, 2000
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS studyK Kantarci, C R Jack, Y C Xu, et al.
Neurocase|July 12, 2005
Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathologyG A Rippon, B F Boeve, J E Parisi, et al.
Neurology|September 1, 2010
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathologyK Kantarci, B F Boeve, Z K Wszolek, et al.
Neurology|April 29, 2009
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRSK Kantarci, S D Weigand, S A Przybelski, et al.
Neurology|July 15, 2011
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRNJ L Whitwell, S D Weigand, J L Gunter, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Neurology|January 28, 2012
The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of AgingR O Roberts, Y E Geda, D S Knopman, et al.
Neurology|September 30, 2009
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutationsJ L Whitwell, C R Jack, B F Boeve, et al.
Neurology|March 4, 2009
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRNJ L Whitwell, C R Jack, B F Boeve, et al.
Neurology|December 22, 2010
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?J L Whitwell, C R Jack, J E Parisi, et al.
Radiology|March 29, 2001
Mild cognitive impairment and Alzheimer disease: regional diffusivity of waterK Kantarci, C R Jack, Y C Xu, et al.
Neurology|July 26, 2000
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS studyK Kantarci, C R Jack, Y C Xu, et al.
Neurocase|July 12, 2005
Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathologyG A Rippon, B F Boeve, J E Parisi, et al.
Neurology|September 1, 2010
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathologyK Kantarci, B F Boeve, Z K Wszolek, et al.
Neurology|April 29, 2009
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRSK Kantarci, S D Weigand, S A Przybelski, et al.
Neurology|July 15, 2011
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRNJ L Whitwell, S D Weigand, J L Gunter, et al.
Pageof 11